The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world performance and clinical outcome of comprehensive genomic profiling of gastrointestinal tumors: High-volume, single-center experience.
 
Gianmarco Ricagno
No Relationships to Disclose
 
Valentina Angerilli
No Relationships to Disclose
 
Giulia Maddalena
No Relationships to Disclose
 
Chiara De Toni
No Relationships to Disclose
 
Jessica Gasparello
No Relationships to Disclose
 
Giulia Barsotti
No Relationships to Disclose
 
Elena Mattiuzzo
No Relationships to Disclose
 
Carlotta Ceccon
No Relationships to Disclose
 
Aldo Montagna
No Relationships to Disclose
 
Marianna Sabbadin
No Relationships to Disclose
 
Chiara Pittarello
No Relationships to Disclose
 
Floriana Nappo
No Relationships to Disclose
 
Riccardo Cerantola
No Relationships to Disclose
 
Francesca Pante
No Relationships to Disclose
 
Letizia Procaccio
No Relationships to Disclose
 
Mario Domenico Rizzato
No Relationships to Disclose
 
Antonio De Rosa
No Relationships to Disclose
 
Matteo Fassan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; GlaxoSmithKline; MSD Oncology; Pierre Fabre; Roche
Research Funding - Astellas Pharma; Diaceutics; Macrophage Pharma; QED Therapeutics
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; SERVIER
Speakers' Bureau - Bayer; Eisai; Lilly; MSD Oncology
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)